Colo et al. found that inhibition of SRC-3 by siRNA increased TRAIL-mediated apoptosis in the human chronic myeloid leukemia cells K562 by depression of NF-κB basal activity [14]. This evidence concerns the gene NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive.